BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26922833)

  • 61. Non-duplex G-Quadruplex DNA Structure: A Developing Story from Predicted Sequences to DNA Structure-Dependent Epigenetics and Beyond.
    Sengupta A; Roy SS; Chowdhury S
    Acc Chem Res; 2021 Jan; 54(1):46-56. PubMed ID: 33347280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tight binding of the antitumor drug ditercalinium to quadruplex DNA.
    Carrasco C; Rosu F; Gabelica V; Houssier C; De Pauw E; Garbay-Jaureguiberry C; Roques B; Wilson WD; Chaires JB; Waring MJ; Bailly C
    Chembiochem; 2002 Dec; 3(12):1235-41. PubMed ID: 12465032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
    Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
    Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
    Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
    Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
    [TBL] [Abstract][Full Text] [Related]  

  • 65. c-MYC promoter G-quadruplex formed at the 5'-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability.
    Mathad RI; Hatzakis E; Dai J; Yang D
    Nucleic Acids Res; 2011 Nov; 39(20):9023-33. PubMed ID: 21795379
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Binding of anticancer drug daunomycin to parallel G-quadruplex DNA [d-(TTGGGGT)]
    Tariq Z; Barthwal R
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1965-1974. PubMed ID: 30287371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NMR based structure reveals groove binding of mitoxantrone to two sites of [d-(TTAGGGT)]
    Tripathi S; Barthwal R
    Int J Biol Macromol; 2018 May; 111():326-341. PubMed ID: 29309865
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methods for investigating G-quadruplex DNA/ligand interactions.
    Murat P; Singh Y; Defrancq E
    Chem Soc Rev; 2011 Nov; 40(11):5293-307. PubMed ID: 21720638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural basis for stabilization of human telomeric G-quadruplex [d-(TTAGGGT)]
    Barthwal R; Raje S; Pandav K
    Bioorg Med Chem; 2020 Dec; 28(23):115761. PubMed ID: 32992248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gaining insights into the small molecule targeting of the G-quadruplex in the c-MYC promoter using NMR and an allele-specific transcriptional assay.
    Kaiser CE; Gokhale V; Yang D; Hurley LH
    Top Curr Chem; 2013; 330():1-21. PubMed ID: 22752577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction of pyrrolobenzodiazepine (PBD) ligands with parallel intermolecular G-quadruplex complex using spectroscopy and ESI-MS.
    Raju G; Srinivas R; Reddy VS; Idris MM; Kamal A; Nagesh N
    PLoS One; 2012; 7(4):e35920. PubMed ID: 22558271
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
    Yin F; Liu J; Deng X; Wang J
    J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quadruplex-Duplex Junction: A High-Affinity Binding Site for Indoloquinoline Ligands.
    Vianney YM; Preckwinkel P; Mohr S; Weisz K
    Chemistry; 2020 Dec; 26(70):16910-16922. PubMed ID: 32975874
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural insights into G-quadruplexes: towards new anticancer drugs.
    Yang D; Okamoto K
    Future Med Chem; 2010 Apr; 2(4):619-46. PubMed ID: 20563318
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
    Kang HJ; Park HJ
    Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-affinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element.
    Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
    Biochemistry; 2007 Sep; 46(37):10433-43. PubMed ID: 17718513
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structures of 1:1 and 2:1 complexes of BMVC and MYC promoter G-quadruplex reveal a mechanism of ligand conformation adjustment for G4-recognition.
    Liu W; Lin C; Wu G; Dai J; Chang TC; Yang D
    Nucleic Acids Res; 2019 Dec; 47(22):11931-11942. PubMed ID: 31740959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An Octahedral Cobalt(III) Complex with Axial NH
    Ruehl CL; Lim AHM; Kench T; Mann DJ; Vilar R
    Chemistry; 2019 Jul; 25(41):9691-9700. PubMed ID: 31087710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
    Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
    J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies on non-covalent interaction of coumarin attached pyrimidine and 1-methyl indole 1,2,3 triazole analogues with intermolecular telomeric G-quadruplex DNA using ESI-MS and spectroscopy.
    Raju G; Srinivas R; Reddy MD; Reddy ChR; Nagesh N
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(7):489-506. PubMed ID: 24972013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.